Applications of 2-Chloro-3-Methyl-5-Nitropyridine in Industrial Manufacturing

As a manufacturer of 2-Chloro-3-Methyl-5-Nitropyridine, we supply this key pyridine derivative to several specialized chemical sectors. Below, we detail the principal downstream application scenarios, highlighting regulatory requirements, technical process integration, formulation specifics, and common finished products produced from this intermediate.

1. Pharmaceutical Intermediate for Anti-Tuberculosis APIs

Major pharmaceutical companies use 2-Chloro-3-Methyl-5-Nitropyridine as a building block in the synthesis of anti-tuberculosis active pharmaceutical ingredients, particularly for molecules featuring nitropyridine scaffolds. Production involves stepwise nucleophilic substitutions followed by reduction or further functional group transformations. Downstream customers typically incorporate our material directly in API synthesis under GMP-controlled conditions to ensure purity and traceability.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• EU Guideline EudraLex Volume 4 (Part II): GMP for APIs
• 21 CFR Part 211 US cGMP for Finished Pharmaceuticals
• Ph. Eur., USP, JP monographs as relevant to API synthesis chain

Typical usage ratio

• Used at 0.4–0.9 molar equivalent in the key coupling reaction. Ratio is adjusted based on downstream yield optimization and impurity profile targets.

Downstream process integration

• Charged into the reaction vessel during the initial API heterocyclic ring construction. Added alongside appropriate base and catalyst under inert atmosphere prior to temperature ramping.

Final product types

• Isoniazid derivatives
• Nitropyridine-based anti-tuberculosis APIs
• Generic anti-infective intermediates featuring pyridine subunits

2. Crop Protection Intermediate for Agrochemical Synthesis

Producers of selective herbicides and fungicides use our pyridine derivative to manufacture advanced active ingredients which benefit from the stability and reactivity of halogen and nitro substitution patterns. Formulators introduce the material in acylation, amination, and coupling steps to develop the final bioactive species efficiently. The product’s high purity is essential for managing off-target activities and achieving consistent field performance.

Industry compliance standards

• ISO 9001 Quality Management System
• FAO/WHO Specification for Pesticide Active Ingredients
• REACH Regulation (EC) No 1907/2006 for safe handling and documentation
• OECD Guidelines for the Testing of Chemicals

Typical usage ratio

• Introduced at 1.1–1.3 molar equivalent versus the primary condensation partner in the core step. Ratio refinement depends on target impurity thresholds and waste minimization.

Downstream process integration

• Added to staged synthesis reactors after solvent charge and base activation. Reactions proceed under controlled temperature and agitation, with downstream extraction and purification steps performed before formulation into technical grade active.

Final product types

• Pyridine-based herbicide AIs
• Systemic fungicide intermediates
• Custom crop protection active ingredients for seed treatment or foliar application

3. Fine Chemical Intermediate for Dye & Pigment Manufacture

Producers of specialty dyes for textiles and printing use our material as a key intermediate for introducing both electron-withdrawing and heteroatomic functional groups into colorant molecules. Typical applications include direct dyes and disperse pigments that exploit the chemical’s stability under harsh processing and coloration conditions. Coordination with downstream partners focuses on maintaining trace metal and halogen content within slippage tolerances to ensure product performance.

Industry compliance standards

• ISO 9001 Quality Management Certification
• Ecological and Toxicological Association of Dyes and Organic Pigments Manufacturers (ETAD) standards
• Textile Eco-label Standards (OEKO-TEX® Standard 100, GOTS for organic textiles)
• EU REACH requirements for safe chemical management

Typical usage ratio

• Concentration in the final dye intermediate blend ranges from 3–10% w/w, determined by desired chromophore density and required color fastness properties.

Downstream process integration

• Feeds into coupling or condensation steps after solvent pre-conditioning. Subsequent azeotropic drying and salt conversion precede spray-drying or granulation for pigment/dye blend formation.

Final product types

• Direct yellow and red textile dyes
• Disperse organic pigment intermediates
• Coloring agents for technical plastics and high-performance coatings

4. Pharmaceutical Intermediate in Sartan-Type Anti-Hypertensive Synthesis

Bulk pharmaceutical plants utilize our compound as a strategic intermediate in multi-step processes leading to angiotensin receptor blocker (sartan) drug substances. The favorable reactivity of both chloro and nitro groups enables selective linkage with biaryl or heteroaryl coupling partners. Strict in-process controls on moisture and trace impurity levels are essential for high-yield and low impurities in the API supply chain.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• WHO cGMP Guidance for Pharmaceutical Manufacturing
• European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) standards applicable to final APIs
• Process Analytical Technology (PAT) for continuous monitoring

Typical usage ratio

• Incorporated at 0.7–1.0 molar equivalent, depending on the route of API construction and reductive functionalization sequence.

Downstream process integration

• Introduced to heteroaryl coupling step post-metalation or prior to Suzuki/Miyaura-type cross-coupling reaction. Downstream isolation and crystallization deliver the penultimate API intermediate.

Final product types

• Sartan class anti-hypertensive APIs (Losartan, Valsartan, etc.)
• Biaryl-heterocyclic intermediates in cardiovascular therapy APIs
• Advanced pharmaceutical intermediates for generic manufacturing

5. Intermediate for Veterinary Active Ingredients

Manufacturers supplying the animal health industry apply this nitropyridine for the synthesis of anthelmintic and antiparasitic agents. Its functional group orientation supports regioselective transformation during the downstream route, which often requires strict control over by-product isomers to meet veterinary drug specifications. The input purity and moisture levels provided are tailored for integration into GMP veterinary lines.

Industry compliance standards

• VICH GL10: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• ISO 9001 Quality Management for Veterinary Manufacturing
• Ph. Eur. Monographs for Veterinary Active Ingredients
• Residue control pursuant to Codex Alimentarius veterinary drug MRLs

Typical usage ratio

• Employed at 0.6–1.0 molar equivalent as dictated by veterinary active ingredient synthesis protocols and risk assessments of downstream variant formation.

Downstream process integration

• Blended into chlorination or reduction reactors following initial charge of co-intermediate. Subsequent purification ensures removal of any secondary nitro impurities prior to API finalization.

Final product types

• Anthelmintic intermediates
• Nitro-pyridine derived veterinary actives for livestock and companion animals
• Broad-spectrum antiparasitic compound precursors

6. Custom Electronic Chemical Synthesis

Specialty electronics companies use our material for the preparation of pyridine-based charge transport intermediates in OLED emitter and organic transistor component manufacturing. The compound’s electronic properties, imparted by nitro and chloro substituents, facilitate high-field performance and controlled electron mobility when polymerized or coupled with triaryl cores. Consistency in isomeric purity and trace ion content are tightly controlled to prevent device failure modes.

Industry compliance standards

• IATF 16949:2016 Automotive Quality Management (for electronic components)
• IPC-5704 Cleanliness Requirements for Unpopulated Printed Boards
• Restriction of Hazardous Substances (RoHS) Directive 2011/65/EU
• ISO 14001 Environmental Management System

Typical usage ratio

• Composes 5–20% of the precursor mix, with precise ratio informed by intended electronic properties and polymerization molecular weight control for the end device layer.

Downstream process integration

• Introduced in micro-encapsulated feed for solution-processing or vapor-phase deposition methods. Recrystallization and final purification steps precede lamination on substrate films for device integration.

Final product types

• OLED charge transport material intermediates
• Organic thin-film transistor (OTFT) base polymers
• Custom semiconducting dye intermediates for display and sensor arrays